Nov 14, 2024 08:00AM
Nov 7, 2024 04:30PM
Oct 28, 2024 08:09AM
Oct 28, 2024 08:00AM
Oct 14, 2024 08:00AM
Oct 7, 2024 08:00AM
Sep 30, 2024 08:00AM Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
Sep 9, 2024 08:00AM
Aug 28, 2024 08:02AM
Aug 28, 2024 08:00AM
Aug 26, 2024 08:00AM
Aug 12, 2024 04:15PM
Aug 12, 2024 04:05PM
Aug 8, 2024 04:30PM Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update
Aug 6, 2024 08:00AM
Jul 18, 2024 08:04AM
Jul 18, 2024 08:00AM
Jul 8, 2024 08:00AM
Jul 8, 2024 08:00AM
Jul 1, 2024 08:00AM
Jul 1, 2024 08:00AM Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
Jun 11, 2024 08:00AM
Jun 11, 2024 08:00AM
May 20, 2024 08:00AM
May 15, 2024 04:05PM
Dec 19, 2023 08:00AM
Dec 19, 2023 08:00AM
Nov 30, 2023 04:48PM Biora Therapeutics (BIOR) Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
Nov 30, 2023 04:48PM
Nov 13, 2023 04:05PM
Nov 6, 2023 08:00AM
Oct 30, 2023 04:06PM
Oct 30, 2023 04:05PM
Oct 24, 2023 05:52AM
Oct 23, 2023 05:30PM Biora Therapeutics to Submit Updated IND Application for BT-600
Sep 25, 2023 08:00AM
Sep 25, 2023 08:00AM
Mar 30, 2023 04:01PM
Mar 30, 2023 04:01PM
Jan 9, 2023 09:00AM
Jan 9, 2023 09:00AM
Jan 9, 2023 09:00AM Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023
Aug 15, 2022 04:05PM
Aug 15, 2022 04:05PM
Jul 14, 2022 12:05PM

322,140 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All